Showing results (41-50 of 8,519) with videos related to
Sort By:
Pageof 852
Alimentary Pharmacology & Therapeutics|July 28, 2010
Systematic review: Helicobacter pylori and the risk of upper gastrointestinal bleeding risk in patients taking aspirinE H Fletcher, D E Johnston, C R Fisher, et al.Alimentary Pharmacology & Therapeutics|July 28, 2010
Meta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinomaA K Singal, D H Freeman, B S AnandAlimentary Pharmacology & Therapeutics|November 9, 2010
Review article: enzyme supplementation in cystic fibrosis, chronic pancreatitis, pancreatic and periampullary cancerC W Imrie, G Connett, R I Hall, et al.Alimentary Pharmacology & Therapeutics|November 25, 2010
Longitudinal direct medical costs associated with constipation in womenR S Choung, M E Branda, D Chitkara, et al.Alimentary Pharmacology & Therapeutics|November 6, 2010
Pilot study: alterations of intestinal microbiota in obese humans are not associated with colonic inflammation or disturbances of barrier functionJ Brignardello, P Morales, E Diaz, et al.Alimentary Pharmacology & Therapeutics|November 6, 2010
A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patientsR Anty, A Iannelli, S Patouraux, et al.Alimentary Pharmacology & Therapeutics|November 6, 2010
Practice patterns for the evaluation and treatment of eosinophilic oesophagitisA F Peery, N J Shaheen, E S DellonAlimentary Pharmacology & Therapeutics|December 24, 2010
Intragastric acidity during administration of generic omeprazole or esomeprazole - a randomised, two-way crossover study including CYP2C19 genotypingS Miehlke, S Löbe, A Madisch, et al.Alimentary Pharmacology & Therapeutics|February 16, 2011
Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux diseaseF Zerbib, S Bruley des Varannes, S Roman, et al.Alimentary Pharmacology & Therapeutics|February 16, 2011
Review article: infliximab for Crohn's disease treatment--shifting therapeutic strategies after 10 years of clinical experienceS Danese, J-F Colombel, W Reinisch, et al.Pageof 852